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Cognitive Impairment in Multiple Sclerosis
Multiple sclerosis (MS) is a lifelong progressive neurologic disease typically diagnosed between ages
20 and 40 years: a time when persons are striving to accomplish normative goals of young adulthood
(e.g., establishing a career).More than half ofMS patients suffer cognitive decline [for review, see Ref.
(1)] especiallymemory problems and cognitive inefficiency (e.g., slowed processing speed, difficulty
multi-tasking).
Clinico-Pathologic Dissociation
There is great variability in cognitive status across MS patients, even among patients with similar
patterns of disease burden/progression (2, 3). This is evidenced in part by the relatively mod-
est/incomplete correlation between MS disease burden (e.g., T2 lesion volume, cerebral atrophy)
and cognitive functions, whether studied cross-sectionally [e.g., Ref. (2)] or longitudinally [e.g., Ref.
(3)]. That is, someMS patients are better able to cope with disease burden without cognitive deficits.
[Note: there is an important and advancing literature on the relationship between cognition and
MRI parameters in persons with MS [e.g., Ref. (4–6)], although a thorough review of this literature
is beyond the scope of this opinion piece. In each case, however, the relationship between disease
burden and cognitive outcomes remains incomplete.] This dissociation between disease burden and
cognitive outcome is common in other neurologic diseases as well, including Alzheimer’s disease
(AD) (7–9). Indeed, some persons accumulate substantial AD neuropathology (e.g., beta-amyloid)
without dementia, whereas other persons suffer dementia at comparable or even lower levels of
pathology (8, 9). These observations have motivated the question: how are some people better able
to withstand neurologic disease burden without cognitive impairment?
Importance of Prediction and Early Intervention to
Prevent Cognitive Decline
Systematic reviews report little-to-no efficacy of pharmacological (10) and behavioral (11) treat-
ments for memory impairment in MS patients. As such, the best treatment of cognitive impairment
inMSmay be the proactive prevention of cognitive decline in the first place. Similarly, treatments for
memory impairment in persons with AD have proven largely ineffective, and research has recently
shifted toward very early pre-clinical intervention to prevent the onset of dementia (which may
represent a point of no return). The science and clinical practice of early intervention/preventative
medicine hinges on our ability to accurately identify patients at greatest risk for future cognitive
decline or dementia. Targeted enrollment of at-risk patients into early intervention trials will
improve statistical power, because beneficial effects of early treatment can only be observed if the
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non-treatment group declines. Enrolling at-risk patients ensures
that there will be adequate cognitive decline for the early inter-
vention to moderate. Clinically, at-risk patients could be targeted
for early interventions to help prevent future cognitive decline,
and earlier treatment takes advantage of the brain’s capacity for
plastic reorganization, which is ostensibly greater at younger ages.
Finally, if risk and protective factors are modifiable, then knowl-
edge of such factors can inform treatment decisions and/or coun-
seling of patients regarding healthy life choices. First, however, we
need to advance our ability to accurately identify MS patients at
greatest risk for future cognitive decline.
Cognitive Reserve Against
Cognitive Decline
The disconnect between disease burden and cognitive status (i.e.,
differential cognitive decline) is explained in part by the cog-
nitive reserve hypothesis (12–14), which posits that enriching
life experiences protect against cognitive decline in the face of
aging and neurologic disease, likely due to greater capacity and
efficiency of neural networks (15, 16). Support for the cognitive
reserve hypothesis has come from evidence that older adults with
a history of greater educational or occupational attainment (17,
18) or engagement in cognitively stimulating leisure activities
(19–21) are at reduced risk for dementia. Importantly, the later
work showed that cognitive leisure activity (e.g., reading, hob-
bies) among healthy elders reduced risk for incident dementia
in the future, suggesting that consideration of such behaviors
in elders may be a useful predictor of future cognitive decline.
Note also that engagement in intellectually enriching activities
moderates/attenuates the deleterious effect of ADneuropathology
on cognitive status in elders (22, 23). Taken together, there is
now amble observational evidence within the aging literature
that lifetime intellectual enrichment and current cognitive leisure
activity lower risk for dementia.
Work by myself and others has extended the cognitive reserve
hypothesis to MS [for review, see Ref. (14)], showing that MS
patients with greater education (24–27) and literacy/vocabulary
(estimatedwith vocabulary) (28–31) are protected against disease-
related cognitive inefficiency and memory problems. We have
also shown, however, that cognitive leisure activity (e.g., reading,
hobbies) contributes to cognitive status in MS patients indepen-
dently of lifetime enrichment (estimated with vocabulary) (32),
and that engagement in such leisure activities during early adult-
hood moderates/attenuates the negative effect of disease burden
(T2 lesion volume) on current cognitive status in MS patients
(33). Others have also shown a benefit of leisure activity against
cognitive impairment in MS (34–36). Longitudinal research on
reserve against cognitive decline has been more limited; how-
ever, Benedict and colleagues have shown that greater intellec-
tual enrichment protects against decline in cognitive efficiency
over nearly 5 years (24), and we have shown that enrichment
is protective against decline in cognitive efficiency and memory
over 4.5 years (31). Longitudinal research highlights the potential
clinical importance of considering a patient’s level of lifetime
enrichment (easily assessed with vocabulary knowledge), which
may be a useful predictor of future cognitive decline (thereby
helping to identify at-risk patients).
FIGURE 1 | This schematic demonstrates the protective effect of
enrichment against cognitive impairment in MS patients, whereby the
negative relationship between cognitive status (y-axis) and MS
disease burden (x-axis) is stronger among patients with lower
enrichment (dashed line) relative to patients with higher enrichment
(solid line). That is, higher enrichment attenuates the negative effect of MS
disease burden on cognitive status. (Note that this schematic was not derived
from actual data, but instead represents the typical pattern of results we have
observed previously.)
On the one hand, we are not surprised that education predicts
cognitive outcomes, as such correlations are observed in healthy
persons as well. Importantly, however, the theory of cognitive
reserve is not based on this main effect of enrichment; rather,
cognitive reserve is instantiated in a moderation/interaction.
Higher enrichment moderates/attenuates the negative relation-
ship between a disease-related variable (e.g., lesion volume, cere-
bral atrophy) and a cognitive outcome (e.g., memory). As such,
the negative impact of disease burden on cognition is actually
greater in persons with lower enrichment than persons with
higher enrichment (see Figure 1). In fact, we have previously
demonstrated that the amount of variance in cognitive outcomes
accounted for by disease burden (e.g., cerebral atrophy) actually
varies based on the educational attainment of the MS sample,
with a stronger relationship between disease burden and cognitive
outcomes in samples with lower education (28). The theory of
cognitive reserve posits that greater intellectual enrichment pro-
tects persons with MS from the negative impact of disease burden
on cognition, leading to different trajectories of cognitive decline
over time [e.g., Ref. (31)].
Brain Reserve Against Cognitive Decline
Separate from the cognitive reserve hypothesis, the theory of brain
reserve capacity (37) proposes that cognitive impairment emerges
when brain volume falls below a critical albeit unspecified thresh-
old. This theory has been supported by observations that elders
with larger head circumference or intracranial volume [proxies
of the brain’s maximal lifetime brain growth (MLBG)] are at
reduced risk for cognitive decline or dementia (38, 39). MLBG
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is considered a proxy of neuronal/synaptic count [see Ref. (40)],
and greater neuronal/synaptic count may (a) be linked to more
robust neural networks resistant to disease-related disruption
and/or (b) providemore potential degrees of freedom for the brain
to plastically reorganize in the face of aging or disease-related
challenges. We have recently shown that larger MLBG lowers
risk for cognitive impairment in MS. Specifically, larger MLBG
(estimated with intracranial volume) moderated/attenuated (a)
the deleterious link between MS disease burden (e.g., T2 lesion
volume) and cognitive efficiency in a cross-sectional sample (33),
and (b) decline in cognitive efficiency over 4.5 years in a lon-
gitudinal sample (31). Note that MLBG was unrelated to mem-
ory function within our MS samples, and closer inspection of
the aging/AD literature suggests that MLBG is protective against
cognitive inefficiency rather than episodic memory deficits [for
discussion, see Ref.(33)]. Note that our cross-sectional (33) and
longitudinal (31) research showed that intellectual enrichment
protects against cognitive inefficiency independently of MLBG,
which is important given the robustmoderate correlation between
brain size and intelligence (41).
Clinical consideration of MLBG may help identify patients at
greatest risk for future cognitive impairment, and such patients
can be targeted for early intervention rehabilitation. Note that
MLBG is almost completely heritable (42) and therefore out-
side of one’s current control; however, patients could be coun-
seled regarding brain healthy choices (e.g., exercise, diet), which
may prevent/slow the loss of reserve brain volume. For instance,
cigarette smoking is particularly damaging for MS patients, and
should be strongly discouraged (43). Also, psychological stress
can exacerbate MS (44), and stress management training has
reduced inflammatory MS lesions (45). Finally, adherence to
pharmaceutical treatments is linked to preservation of function
(46), as disease-modifying therapies are effective in reducing cere-
bral atrophy (preserving brain reserve) in MS patients (47). This
notion of maintaining brain reserve by avoiding risk factors for
neuropathology is reviewed elsewhere as the concept of “brain
maintenance” in aging (48).
Building Reserve Against
Cognitive Impairment
Cognitive reserve is an appealing concept. It suggests that persons
can reduce their risk of age- or disease-related cognitive decline by
actively pursuing intellectually enriching lifestyles. Note, however,
that evidence for the cognitive reserve hypothesis in aging and
neurologic populations is almost entirely observational, thereby
preventing causal statements about the protective effects of cog-
nitive stimulation. As such, a great deal of more rigorous work
is needed before we can “prescribe” specific programs of enrich-
ment, including true experiments/randomized controlled trials
of intellectual enrichment. That said, engagement in mentally
stimulating activities represents a cost-effective, non-invasive way
for healthy persons andMS patients to actively participate in their
own cognitive health. This is non-trivial, as the unpredictable
nature of MS disease often results in an external locus of control
(49), leading to hopelessness and depression. MS patients should
be encouraged to remain cognitively active from the time of
diagnosis onward.
One important avenue for future research will be to identify
modifiable neuroanatomical bases for the protective effect of
reserve. We have recently linked engagement in cognitive leisure
activity to larger hippocampal volume in persons with MS (35),
which is consistent with the well-established effects of enrichment
on the hippocampus in basic research [for review, see Ref. (50)],
as well as links between enrichment and hippocampal volume
in older humans (51, 52). Once we identify the neuroanatomical
basis for reserve, we can use these as structural targets in early
intervention work to evaluate whether preventative treatments
have increased reserve. The alternative is to wait for years to see
if an early intervention led to differential cognitive decline in
the future, but neuroanatomical targets provide more immediate
feedback on the efficacy of early interventions. Discovery of mod-
ifiable neuroanatomical bases of reserve also allows us to expand
our efforts beyond cognitively based interventions (e.g., intellec-
tual enrichment) to include other interventions/protective factors
linked to the health of neuroanatomical targets. For instance,
regarding the hippocampus, one of the most promising treat-
ments across neurologic populations may be aerobic exercise
training. Indeed, basic research reports strong support for the
role of exercise in stimulating hippocampal neurogenesis and
memory [e.g., Ref. (53)], which is being translated into humans
[e.g., Ref. (54), for review, see Ref. (55)]. We have previously
reported a case study linking aerobic exercise training to increased
hippocampal volume, improved memory, and enhanced default
network functional connectivity in MS (56), and aerobic exer-
cise training in progressive MS patients appears promising (57).
Outside of aerobic exercise training, there are many bene-
fits of physical exercise for cognition generally in MS patients
[for review, see Ref. (58)].
Conclusion
The theory of reserve provides a useful framework for the science
and clinical practice of early intervention against cognitive decline
inMS patients (i.e., preventativemedicine). First, consideration of
a patient’sMLBG and level of lifetime intellectual enrichmentmay
help identify patients at greatest risk for future cognitive decline.
These at-risk patients can be targeted for early intervention cog-
nitive rehabilitation, or research on such treatments. Toward this
end, future research should develop and test algorithms to pre-
dict risk of cognitive decline in MS patients, which should take
proxies of reserve (as well as other risk factors, e.g., smoking)
into consideration. Second, intellectual enrichment programsmay
provide an early intervention treatment in itself; however, all
existing evidence is observational, so rigorous experimental work
is necessary to establish causal relationships between enrichment
and protection against cognitive decline. Finally, the use ofMRI or
fMRI to identify neuroanatomical or functionalmarkers of reserve
will be helpful in providing measurable proxies for increased
reserve as outcomes of early intervention trials. Such targets will
provide an immediate evaluation of an interventions efficacy to
increase reserve, which can then be validated by differential cog-
nitive decline in the future. There is indeed much more work to
be done to translate the concept of reserve into a clinically useful
tool for prediction of decline, evaluation of treatment efficacy, and
treatment itself for MS patients.
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